1. Home
  2. KNTK vs MLTX Comparison

KNTK vs MLTX Comparison

Compare KNTK & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNTK
  • MLTX
  • Stock Information
  • Founded
  • KNTK 2017
  • MLTX 2021
  • Country
  • KNTK United States
  • MLTX Switzerland
  • Employees
  • KNTK N/A
  • MLTX N/A
  • Industry
  • KNTK Natural Gas Distribution
  • MLTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • KNTK Utilities
  • MLTX Health Care
  • Exchange
  • KNTK Nasdaq
  • MLTX Nasdaq
  • Market Cap
  • KNTK 2.6B
  • MLTX 2.8B
  • IPO Year
  • KNTK N/A
  • MLTX N/A
  • Fundamental
  • Price
  • KNTK $41.84
  • MLTX $55.75
  • Analyst Decision
  • KNTK Buy
  • MLTX Strong Buy
  • Analyst Count
  • KNTK 9
  • MLTX 7
  • Target Price
  • KNTK $54.89
  • MLTX $74.83
  • AVG Volume (30 Days)
  • KNTK 1.4M
  • MLTX 399.5K
  • Earning Date
  • KNTK 08-06-2025
  • MLTX 08-05-2025
  • Dividend Yield
  • KNTK 7.46%
  • MLTX N/A
  • EPS Growth
  • KNTK N/A
  • MLTX N/A
  • EPS
  • KNTK 0.73
  • MLTX N/A
  • Revenue
  • KNTK $1,652,079,000.00
  • MLTX N/A
  • Revenue This Year
  • KNTK $32.04
  • MLTX N/A
  • Revenue Next Year
  • KNTK $25.28
  • MLTX N/A
  • P/E Ratio
  • KNTK $57.03
  • MLTX N/A
  • Revenue Growth
  • KNTK 19.71
  • MLTX N/A
  • 52 Week Low
  • KNTK $39.25
  • MLTX $31.42
  • 52 Week High
  • KNTK $67.60
  • MLTX $58.26
  • Technical
  • Relative Strength Index (RSI)
  • KNTK 52.17
  • MLTX 59.35
  • Support Level
  • KNTK $40.89
  • MLTX $53.29
  • Resistance Level
  • KNTK $42.61
  • MLTX $56.78
  • Average True Range (ATR)
  • KNTK 1.08
  • MLTX 2.07
  • MACD
  • KNTK 0.23
  • MLTX -0.05
  • Stochastic Oscillator
  • KNTK 69.72
  • MLTX 78.36

About KNTK Kinetik Holdings Inc.

Kinetik Holdings Inc is a midstream operator that provides gathering and processing services to gas and oil producers as well as pipeline transportation. In addition to directly operating pipelines, Kinetik also holds ownership stakes in several pipelines. The company operates in two reportable segments which include The Midstream Logistics segment operates under three service offerings, 1) gas gathering and processing, 2) crude oil gathering, stabilization, and storage services, and 3) produced water gathering and disposal. The Pipeline Transportation segment consists of three EMI pipelines originating in the Permian Basin with various access points to the U.S. Gulf Coast, Kinetik NGL Pipelines, and Delaware Link Pipeline.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

Share on Social Networks: